Myelin Protein Zero-Like 2 (MPZL2) (N-Term) Peptide
MPZL2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MPZL2 products
- MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MPZL2 antibody (Catalog #: ARP46654_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))
- Background
-
Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous
Alias Symbols: EVA, EVA1
Protein Size: 215 - Molecular Weight
- 22 kDa
- Gene ID
- 10205
- NCBI Accession
- NM_005797, NP_005788
- UniProt
- O70255
-
You are here:
